Results 101 to 110 of about 250,304 (196)

Cyclin D1 protein expression in lung cancer

, 1996
Cyclin D1, a G1 cyclin, has been implicated in the oncogenesis of various types of malignancies via deregulation of cell cycles. Amplification of cyclin D1 as a part of 11q13 amplicon has been reported in lung cancer as well as a subset of carcinomas ...
양우익, 정경영
core   +1 more source

Transizyonel hücreli mesane kanserinde cyclin-D1 proto-onkojen ekspresyonu

, 1999
Öz: Bu çalışmada yüzeyel mesane kanserlerinde hücre-siklus düzenleyici proteinlerden cyclin-D1 onkoprotein ekpresyonunu ve bunun tümör greydi ile ilişkisi araştırıldı. Çalışmaya 45 mesane kanserli hastaya ait parafinize tümör dokusu alındı.
Mızrak, Bülent, Soylu, Ahmet, Ongun, Melda, Gürpınar, Tayfun, Ateşçi, Y. Ziya, Özbek, Emin   +5 more
core   +1 more source

Differential expression of cyclin D1 in pituitary neuroendocrine tumours: Relation to aggressive potential. [PDF]

Afr J Lab Med
Uchime KE, Awolola NA, Anunobi CC, Bankole OB, Banjo AA, Park SH.   +5 more
europepmc   +1 more source

IL-13Rα2 Regulates C2C12 Myoblast Proliferation via the Akt-Cyclin D1-CDK4 Pathway. [PDF]

Int J Mol Sci
Kurosaka M, Kohda K.
europepmc   +1 more source

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc

, 2009
During estrogen-induced proliferation, c-Myc and cyclin D1 initiate independent pathways that activate cyclin E1-Cdk2 by sequestration and/or downregulation of the CDK inhibitor p21Waf1/Cip1, without significant increases in cyclin E1 protein levels.
Elizabeth A. Musgrove, C. Elizabeth Caldon, C. Marcelo Sergio, Marijke N. Boersma, Robert L. Sutherl, Jason S. Carroll   +5 more
core  

AI-Assisted Identification of a Putative Allosteric Ligand Targeting the CDK4/Cyclin D1 Protein-Protein Interface. [PDF]

Pharmaceuticals (Basel)
Kurt B.
europepmc   +1 more source

Cytoplasmic cyclin D1 modulates brain cortex development. [PDF]

Cell Mol Life Sci
Pedraza N, Rocandio D, Zammou B, Monserrat MV, Ortiz-Brugués A, Marfull-Oromí P, Chauhan D, Encinas M, Dolcet X, Ferrezuelo F, Garí E, Egea J.   +11 more
europepmc   +1 more source

A cyclin D1-CDK4/6-E2F dependency represents an acquired vulnerability in cisplatin-resistant bladder cancer. [PDF]

Biol Direct
Hsieh TH, Kuo HP, Pan CH, Lin YC, Lin BJ, Chen MC, Chen CH.   +6 more
europepmc   +1 more source

Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial. [PDF]

Blood Cancer J
Perrot A, Touzeau C, Minvielle S, Hulin C, Caillot D, Manier S, Leleu X, Sonntag C, Belhadj K, Arnulf B, Chalopin T, Eveillard JR, Escoffre-Barbe M, Karlin L, Vincent L, Macro M, Avet-Loiseau H, Wuilleme S, Boumendil A, Corre J, Moreau P.   +20 more
europepmc   +1 more source

Transient proliferation by reversible YAP and mitogen control of the cyclin D1/p27 ratio. [PDF]

Commun Biol
Ferrick KR, Upadhya SW, Fan Y, Ratnayeke N, Teruel MN, Meyer T.   +5 more
europepmc   +1 more source